Showing results (371-380 of 2,338) with videos related to

Sort By:
Pageof 234
Clinical Lung Cancer|December 12, 2018
Results of a Phase II Placebo-controlled Randomized Discontinuation Trial of Cabozantinib in Patients with Non-small-cell Lung CarcinomaBeth A Hellerstedt, Nicholas J Vogelzang, Harriet M Kluger, et al.
Clinical Lung Cancer|August 21, 2017
High-resolution Computed Tomography Features Distinguishing Benign and Malignant Lesions Manifesting as Persistent Solitary Subsolid NodulesWenjia Yang, Yifeng Sun, Wentao Fang, et al.
Clinical Lung Cancer|January 30, 2019
Immunotherapy for LELC: Case Report and a Focused ReviewMarie Darrason, Antoine Martin, Michael Soussan, et al.
Clinical Lung Cancer|February 6, 2018
Real-world Efficacy and Safety of Nivolumab for Advanced Non-Small-cell Lung Cancer: A Retrospective Multicenter AnalysisKeigo Kobayashi, Ichiro Nakachi, Katsuhiko Naoki, et al.
Clinical Lung Cancer|January 17, 2018
Developing a Predictive Model for Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Treated With NivolumabWungki Park, Deukwoo Kwon, Diana Saravia, et al.
Clinical Lung Cancer|January 18, 2018
Distinct MET Protein Localization Associated With MET Exon 14 Mutation Types in Patients With Non-small-cell Lung CancerTian Qiu, Weihua Li, Tongtong Zhang, et al.
Clinical Lung Cancer|January 11, 2018
Randomized, Double-Blind Phase Ib/III Study of Erlotinib With Ramucirumab or Placebo in Previously Untreated EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer (RELAY): Phase Ib ResultsMartin Reck, Edward B Garon, Luis Paz-Ares, et al.
Clinical Lung Cancer|July 21, 2021
Efficacy and Safety of Combined Brain Radiotherapy and Immunotherapy in Non-Small-Cell Lung Cancer With Brain Metastases: A Systematic Review and Meta-AnalysisYin Yang, Lei Deng, Yufan Yang, et al.
Clinical Lung Cancer|May 25, 2022
Rationale and Design of the Phase 3 KEYLYNK-013 Study of Pembrolizumab With Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Limited-Stage Small-Cell Lung CancerAndreas Rimner, Wei-Chu Victoria Lai, Raffaele Califano, et al.
Clinical Lung Cancer|May 26, 2022
Long-Term Survival of Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor Monotherapy in Real-World SettingsTaro Yoneda, Takashi Sone, Hayato Koba, et al.
Pageof 234